Preclinical Activity of VX-787, a First-in-Class, Orally Bioavailable Inhibitor of the Influenza Virus Polymerase PB2 Subunit

Prevalence and control of H7 avian influenza viruses in birds and humans

(2014) E. M. ABDELWHAB et al.   EPIDEMIOLOGY AND INFECTION

Discovery of a Novel, First-in-Class, Orally Bioavailable Azaindole Inhibitor (VX-787) of Influenza PB2

(2014) Michael P. Clark et al.   JOURNAL OF MEDICINAL CHEMISTRY

Clinical and epidemiological characteristics of a fatal case of avian influenza A H10N8 virus infection: a descriptive study

(2014) HaiYing Chen et al.   LANCET

The epidemiology and spread of drug resistant human influenza viruses

(2014) Aeron C Hurt   Current Opinion in Virology

New 7-Methylguanine Derivatives Targeting the Influenza Polymerase PB2 Cap-Binding Domain

(2013) Stéphane Pautus et al.   JOURNAL OF MEDICINAL CHEMISTRY

Epidemiology of Human Infections with Avian Influenza A(H7N9) Virus in China

(2013) Qun Li et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Value of Neuraminidase Inhibitors for the Prevention and Treatment of Seasonal Influenza: A Systematic Review of Systematic Reviews

(2013) Barbara Michiels et al.   PLoS One

Targeting the host or the virus: Current and novel concepts for antiviral approaches against influenza virus infection

(2012) Suki Man-Yan Lee et al.   ANTIVIRAL RESEARCH

Treatment With Neuraminidase Inhibitors for Critically Ill Patients With Influenza A (H1N1)pdm09

(2012) J. K. Louie et al.   CLINICAL INFECTIOUS DISEASES

Screening methods for influenza antiviral drug discovery

(2012) Colm Atkins et al.   Expert Opinion on Drug Discovery

Antivirals in seasonal and pandemic influenza-future perspectives*

(2012) Michael W. Wathen et al.   Influenza and Other Respiratory Viruses

Newer influenza antivirals, biotherapeutics and combinations

(2012) Frederick G. Hayden   Influenza and Other Respiratory Viruses

Estimates of Influenza Vaccine Effectiveness for 2007–2008 From Canada's Sentinel Surveillance System: Cross-Protection Against Major and Minor Variants

(2012) Naveed Z. Janjua et al.   JOURNAL OF INFECTIOUS DISEASES

Global production capacity of seasonal influenza vaccine in 2011

(2012) Jeffrey Partridge et al.   VACCINE

Systematic review of influenza resistance to the neuraminidase inhibitors

(2011) Kristian Thorlund et al.   BMC INFECTIOUS DISEASES

The global spread of drug-resistant influenza

(2011) D. L. Chao et al.   Journal of the Royal Society Interface

Inhibition of influenza virus replication via small molecules that induce the formation of higher-order nucleoprotein oligomers

(2011) S. W. Gerritz et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The host interactome of influenza virus presents new potential targets for antiviral drugs

(2011) Megan L. Shaw   REVIEWS IN MEDICAL VIROLOGY

Pandemic Influenza’s 500th Anniversary

(2010) David M. Morens et al.   CLINICAL INFECTIOUS DISEASES

Pandemic 2009 Influenza A(H1N1) Virus Illness Among Pregnant Women in the United States

(2010) Alicia M. Siston   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Adaptation of Pandemic H1N1 Influenza Viruses in Mice

(2010) N. A. Ilyushina et al.   JOURNAL OF VIROLOGY

Cellular targets for influenza drugs

(2010) Ji-Young Min et al.   NATURE BIOTECHNOLOGY

Influenza Vaccines for the Future

(2010) Linda C. Lambert et al.   NEW ENGLAND JOURNAL OF MEDICINE

Neuraminidase Inhibitor Susceptibility Testing in Human Influenza Viruses: A Laboratory Surveillance Perspective

(2010) Margaret Okomo-Adhiambo et al.   Viruses-Basel

The role of the influenza virus RNA polymerase in host shut-off

(2010) Frank T. Vreede et al.   Virulence

Biological and Structural Characterization of a Host-Adapting Amino Acid in Influenza Virus

(2010) Shinya Yamada et al.   PLoS Pathogens

Potential Targets and Their Relevant Inhibitors in Anti-influenza Fields

(2009) Jianzhi Gong et al.   CURRENT MEDICINAL CHEMISTRY

The Evolution of Influenza Resistance and Treatment

(2009) David M. Weinstock   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Mechanisms and functional implications of the degradation of host RNA polymerase II in influenza virus infected cells

(2009) Frank T. Vreede et al.   VIROLOGY

The structural basis for cap binding by influenza virus polymerase subunit PB2

(2008) Delphine Guilligay et al.   NATURE STRUCTURAL & MOLECULAR BIOLOGY

Injectable peramivir mitigates disease and promotes survival in ferrets and mice infected with the highly virulent influenza virus, A/Vietnam/1203/04 (H5N1)

(2008) Nadezhda E. Yun et al.   VIROLOGY